Disclosure Of Entity's Operating Segments [Text Block]

Affluent Medical - Filing #882835

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
- EUR
- EUR
Depreciation and amortisation expense
2 420 EUR
1 907 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
14,000 EUR
398,000 EUR
Tax expense (income)
437,000 EUR
209,000 EUR
Profit (loss) before tax
15 257 EUR
14 528 EUR
Profit (loss)
- EUR
14 820 EUR
- EUR
- EUR
- EUR
- EUR
14 820 EUR
14 820 EUR
14 319 EUR
- EUR
- EUR
- EUR
- EUR
14 319 EUR
14 319 EUR
- EUR
Assets
70 035 EUR
64 826 EUR
Investments accounted for using equity method
- EUR
14,000 EUR
Cash flows from (used in) operating activities
12 364 EUR
8 936 EUR
Cash flows from (used in) investing activities
160,000 EUR
304,000 EUR
Cash flows from (used in) financing activities
18 281 EUR
12 762 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.